The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This session provides an analysis and discussion of the role evidence-based practice can play in improving the treatment and outcome for CKD patients with mineral bone disorders. Discussion focuses on the success of current evidence-based practices that support the early and aggressive treatment of hyperphosphatemia, along with the role that hypercalcemia can play in treatment, and a comparison of the pharmacotherapeutic agents available to help treat these disorders is explored.